Haemonetics (HAE) Tops Q2 EPS by 7c, Beats on Revenues
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.80 +0.54%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.48, $0.07 better than the analyst estimate of $0.41. Revenue for the quarter came in at $225 million versus the consensus estimate of $219.26 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
- Haemonetics (HAE) PT Raised to $119 at Baird
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
